Is Homocysteine a Risk Factor for Atherothrombotic Cardiovascular Disease?

Journal of the American College of Cardiology

Volumn 49, Issue 12, 2007, Pages 1370-1371

  Akhtar, Naveed ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ACUTE HEART INFARCTION; ATHEROMA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; HUMAN; INDIA; LETTER; MORTALITY; PAKISTAN; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; UNITED STATES;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; HOMOCYSTEINE; HUMANS; RISK FACTORS; THROMBOSIS;

EID: 33947494510     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.01.014     Document Type: Letter

References (20)

1. Kaul S., Zadeh A.A., and Shah P.K. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. J Am Coll Cardiol 48 (2006) 914-923
2. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
3. Salahuddin M.I., and Ahmed S.I. Homocysteine level in patients with established transmural myocardial infarction. J Coll Physicians Surg Pak 15 (2005) 520-523
4. Aamir M., Sattar A., Dawood M.M., et al. Hyperhomocysteinemia as a risk factor for ischemic heart disease. J Coll Physicians Surg Pak 14 (2004) 518-521
5. Iqbal M.P., Ishaq M., Kazmi K.A., et al. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis 15 (2005) 100-108
6. Nishtar S., Wierzbicki A.S., Lumb P.J., et al. Waist-hip ratio and low HDL predict the risk of coronary artery disease in Pakistanis. Curr Med Res Opin 20 (2004) 55-62
7. Akhtar N., Alam M.T., Adil M.M., et al. Homocysteine and coronary artery disease in Pakistan. Pakistan J Cardiol 16 (2005) 131-137
8. Refsum H., Yajnik C.S., Gadkari M., et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 74 (2001) 233-241
9. Nishtar S. Prevention of coronary heart disease in South Asia. Lancet 360 (2002) 1015-1018
10. In: Yusuf S., Cairns J.A., Camm A.J., et al. (Eds). Evidence-Based Cardiology (2003), BMJ Books, London 264-267
11. Kuller L.H. Prevention of cardiovascular disease and the future cardiovascular disease epidemiology. Int J Epidemiol Suppl 1 (2001) S66-S72
12. Samad A. Coronary artery disease in Pakistan: preventive aspects. Pakistan J Cardiol 14 (2003) 59-60
13. The Heart Outcomes Prevention Evaluation (H.O.P.E.) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 (2006) 1567-1577
14. Bonaa K.H., Njolstad I., Ueland P.M., et al., NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588
15. Bostom A.G., Selhub J., Jacques P.F., et al. Power shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour. Ann Intern Med 135 (2001) 133-137
16. Lange H., Suryapranata H., De Luca G., et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 350 (2004) 2673-2681
17. Anderson J.L., Jensen K.R., Carlquist J.F., et al. Effect of folic acid fortification of food on homocysteine-related mortality. Am J Med 116 (2004) 158-164
18. Yang Q., Botto L.D., Erickson J.D., et al. Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113 (2006) 1335-1343
19. Global Forum Health Research: Helping Correct the 10/90 Gap. Available at: http://www.globalforumhealth.org/Site/003_The%2010%2090%20gap/001_Now.php. Accessed September 2006.
20. DeMaria A.N. Editor's page: diversity in JACC. J Am Coll Cardiol 47 (2006) 2561-2562